| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Peter S Yoo | |
| Charles H Cha | |||
| Abby L Mulkeen | |||
| P2860 | cites work | Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 |
| Two independent internal ribosome entry sites are involved in translation initiation of vascular endothelial growth factor mRNA | Q24522773 | ||
| Suppression of vascular endothelial growth factor expression at the transcriptional and post-transcriptional levels | Q24793942 | ||
| Tumor angiogenesis: therapeutic implications | Q27860595 | ||
| RNA interference is mediated by 21- and 22-nucleotide RNAs | Q27860764 | ||
| Role for a bidentate ribonuclease in the initiation step of RNA interference | Q27860832 | ||
| Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 | ||
| Internal ribosome entry sites in eukaryotic mRNA molecules | Q28205551 | ||
| Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells | Q28215061 | ||
| Hypoxia increases the association of 4E-binding protein 1 with the initiation factor 4E in isolated rat hepatocytes | Q28567254 | ||
| Differential expression of VEGF isoforms in mouse during development and in the adult | Q28592341 | ||
| Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
| HuR and mRNA stability | Q29615185 | ||
| Vascular endothelial growth factor (VEGF) and its receptors | Q29615390 | ||
| Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs | Q29620269 | ||
| Control of the vascular endothelial growth factor internal ribosome entry site (IRES) activity and translation initiation by alternatively spliced coding sequences | Q75424426 | ||
| Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion | Q77847672 | ||
| A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer | Q81280772 | ||
| New horizons for VEGF. Is there a role for nuclear localization? | Q81395448 | ||
| Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. | Q30944070 | ||
| Angiogenesis: regulators and clinical applications | Q31923131 | ||
| Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites | Q31957370 | ||
| HNS, a nuclear-cytoplasmic shuttling sequence in HuR | Q33579107 | ||
| MYC oncogenes and human neoplastic disease | Q33667340 | ||
| Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia | Q33772948 | ||
| HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression | Q33968465 | ||
| A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. | Q34113282 | ||
| Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate | Q36220799 | ||
| Approaches for chemically synthesized siRNA and vector-mediated RNAi | Q36274423 | ||
| Barriers to gene delivery using synthetic vectors. | Q36293293 | ||
| Excessive tumor-elaborated VEGF and its neutralization define a lethal paraneoplastic syndrome | Q36312006 | ||
| Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray | Q36667026 | ||
| Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis | Q38290076 | ||
| Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. | Q38324116 | ||
| Role of the RNA-binding protein HuR in colon carcinogenesis | Q38349167 | ||
| Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein | Q38352366 | ||
| The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. | Q40241912 | ||
| Central administration of small interfering RNAs in rats: a comparison with antisense oligonucleotides | Q40364125 | ||
| Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translation | Q40484659 | ||
| Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor. | Q40839188 | ||
| Initiation of protein synthesis in eukaryotic cells | Q41006460 | ||
| Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability | Q41308865 | ||
| Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant | Q41488146 | ||
| The mRNA 5' cap-binding protein eIF4E and control of cell growth | Q41751015 | ||
| The vascular endothelial growth factor mRNA contains an internal ribosome entry site. | Q42826373 | ||
| New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation | Q43814572 | ||
| Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. | Q44393459 | ||
| Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer | Q45861347 | ||
| Improved co-expression of multiple genes in vectors containing internal ribosome entry sites (IRESes) from human genes. | Q45884844 | ||
| Post-transcriptional regulation of vascular endothelial growth factor by hypoxia | Q48066359 | ||
| The elav gene product of Drosophila, required in neurons, has three RNP consensus motifs. | Q52249136 | ||
| SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. | Q53923164 | ||
| Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. | Q55480542 | ||
| Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer | Q59263687 | ||
| The proto-oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas | Q59263746 | ||
| Immunological detection of the messenger RNA cap-binding protein | Q69896609 | ||
| Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis | Q71081146 | ||
| Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors | Q73121301 | ||
| Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study | Q73435945 | ||
| Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma | Q73894010 | ||
| Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer | Q74067245 | ||
| Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis | Q74114483 | ||
| Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR | Q74299380 | ||
| P433 | issue | 31 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| tumor angiogenesis | Q110495869 | ||
| P304 | page(s) | 4937-4942 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Post-transcriptional regulation of vascular endothelial growth factor: implications for tumor angiogenesis | |
| P478 | volume | 12 |
| Q36742493 | ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response |
| Q35891224 | AUF1/hnRNP D represses expression of VEGF in macrophages |
| Q36086891 | Abnormal histone methylation is responsible for increased vascular endothelial growth factor 165a secretion from airway smooth muscle cells in asthma |
| Q35933136 | Andes Hantavirus-Infection of a 3D Human Lung Tissue Model Reveals a Late Peak in Progeny Virus Production Followed by Increased Levels of Proinflammatory Cytokines and VEGF-A |
| Q39641982 | Association between expression of embryonic lethal abnormal vision‐like protein HuR and cyclooxygenase‐2 in oral squamous cell carcinoma |
| Q42733340 | Blanching the airways: steroid effects in asthma. |
| Q51356864 | Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells. |
| Q35759889 | Cancer cell: using inflammation to invade the host. |
| Q54341750 | Effects of down-regulation of microRNA-23a on TNF-α-induced endothelial cell apoptosis through caspase-dependent pathways. |
| Q36407908 | Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer. |
| Q34787415 | Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways |
| Q46580319 | Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human astrocytic tumors |
| Q40006087 | Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas. |
| Q49382862 | Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells. |
| Q39342887 | Intermedin is overexpressed in hepatocellular carcinoma and regulates cell proliferation and survival |
| Q34205259 | Intestinal epithelial HuR modulates distinct pathways of proliferation and apoptosis and attenuates small intestinal and colonic tumor development |
| Q38357262 | Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells |
| Q36562557 | Measurements of CD34+/CD45-dim Stem Cells Predict Healing of Diabetic Neuropathic Wounds |
| Q36673482 | MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. |
| Q58108714 | Multiple functions of HuR in urinary tumors |
| Q28290458 | Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis |
| Q37344097 | Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of PTC299, an Inhibitor of Stress-Regulated Protein Translation |
| Q34065213 | Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements |
| Q34023658 | Regulation of the mRNA half-life in breast cancer |
| Q30591171 | The translation initiation factor eIF3i up-regulates vascular endothelial growth factor A, accelerates cell proliferation, and promotes angiogenesis in embryonic development and tumorigenesis |
| Q37325542 | Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival |
| Q42946802 | Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer |
| Q36929380 | Vascular endothelial growth factor in eye disease |
| Q28115802 | ZFP36L1 is regulated by growth factors and cytokines in keratinocytes and influences their VEGF production |
Search more.